Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.
Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.
复制标题
DOI:
10.1074/jbc.m110.217083
复制
发表时间:
2011-07-15
期刊:
影响因子:
--
通讯作者:
Pradhan S
中科院分区:
文献类型:
--
作者:
Kinney SM;Chin HG;Vaisvila R;Bitinaite J;Zheng Y;Estève PO;Feng S;Stroud H;Jacobsen SE;Pradhan S
Cytosine residues in the vertebrate genome are enzymatically modified to 5-methylcytosine, which participates in transcriptional repression of genes during development and disease progression. 5-Methylcytosine can be further enzymatically modified to 5-hydroxymethylcytosine by the TET family of methylcytosine dioxygenases. Analysis of 5-methylcytosine and 5-hydroxymethylcytosine is confounded, as these modifications are indistinguishable by traditional sequencing methods even when supplemented by bisulfite conversion. Here we demonstrate a simple enzymatic approach that involves cloning, identification, and quantification of 5-hydroxymethylcytosine in various CCGG loci within murine and human genomes. 5-Hydroxymethylcytosine was prevalent in human and murine brain and heart genomic DNAs at several regions. The cultured cell lines NIH3T3 and HeLa both displayed very low or undetectable amounts of 5-hydroxymethylcytosine at the examined loci. Interestingly, 5-hydroxymethylcytosine levels in mouse embryonic stem cell DNA first increased then slowly decreased upon differentiation to embryoid bodies, whereas 5-methylcytosine levels increased gradually over time. Finally, using a quantitative PCR approach, we established that a portion of VANGL1 and EGFR gene body methylation in human tissue DNA samples is indeed hydroxymethylation.